ConductScience.org, home

Paper8555890

Acyclovir in recurrent herpes labialis.

Worrall G. BMJ, 1996. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Acyclovir in recurrent herpes labialis. Papers, record 8555890. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8555890

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Acyclovir in recurrent herpes labialis.
PubMed
Journal
BMJ
PubMed
Year
1996
PubMed
Publication types
Editorial
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2019-05-01
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Worrall GG

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcyclovirMajor topic
Antiviral AgentsMajor topic
Herpes LabialisMajor topic
Clinical Trials as Topic
Humans
Recurrence

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in8616328Topical acyclovir is beneficial in recurrent herpes labialis.https://conductscience.org/library/papers/8616328

Source PubMed

Download CSV of comments and corrections

References9

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16368877Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.JAMA1984https://conductscience.org/library/papers/6368877PubMed
28380540Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.Ann Intern Med1993https://conductscience.org/library/papers/8380540PubMed
321234082Topical Acyclovir for Recurrent Herpes Labialis in Primary Care: Critical appraisal.Can Fam Physician1991https://conductscience.org/library/papers/21234082PubMed
41849159The natural history of ultraviolet radiation-induced herpes simplex labialis and response to therapy with peroral and topical formulations of acyclovir.J Infect Dis1991https://conductscience.org/library/papers/1849159PubMed
54347057Recovery of herpes-simplex virus from human trigeminal ganglions.N Engl J Med1973https://conductscience.org/library/papers/4347057PubMed
6216753The natural history of recurrent facial-oral infection with herpes simplex virus.J Infect Dis1978https://conductscience.org/library/papers/216753PubMed
755654An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins.Lancet1976https://conductscience.org/library/papers/55654PubMed
88245889Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis.J Med Virol1993https://conductscience.org/library/papers/8245889PubMed
96703544Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.Ann Intern Med1984https://conductscience.org/library/papers/6703544PubMed

Download CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
39881894A Rare Case of Viral Meningitis and Probable Metabolic Encephalopathy in a Renal Transplant Patient.Cureus2024https://conductscience.org/library/papers/39881894PubMed
34728865Broad spectrum antiviral nucleosides-Our best hope for the future.Annu Rep Med Chem2021https://conductscience.org/library/papers/34728865PubMed
30362389Clinical Trial of Herbal Treatment Gene-Eden-VIR/Novirin in Oral Herpes.J Evid Based Integr Med2018https://conductscience.org/library/papers/30362389PubMed
26252373Interventions for prevention of herpes simplex labialis (cold sores on the lips).Cochrane Database Syst Rev2015https://conductscience.org/library/papers/26252373PubMed
8664786Evidence for efficacy of topical acyclovir in recurrent herpes labialis is weak.BMJ1996https://conductscience.org/library/papers/8664786PubMed
8616328Topical acyclovir is beneficial in recurrent herpes labialis.BMJ1996https://conductscience.org/library/papers/8616328PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8555890

GET https://conductscience.org/api/papers/v1/8555890/authors